Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study.
Ehab Atallah, Brent Logan, Min Chen...
https://pubmed.ncbi.nlm.nih.gov/31830234Actively Recruiting
Led by Center for International Blood and Marrow Transplant Research · Updated on 2025-08-12
99999999
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are gathering comprehensive observational data on hematopoietic stem cell (HSC) transplantation, other cellular therapies, and marrow toxic injuries to better understand these treatments and their outcomes. The study aims to learn what factors contribute to successful stem cell transplants and cellular therapies, including patient recovery, genetic influences, and access to treatments. It also seeks to improve donor recovery after collection procedures and study marrow toxic injuries comprehensively. This is an observational research database without specific treatments or interventions assigned to participants. It includes recipients of unrelated, related donor, or autologous HSC transplants, individuals treated for marrow toxic injuries, and donors registered on the National Marrow Donor Program (NMDP) Registry. Data collection is ongoing and does not direct clinical care or treatment choices. Participants contribute data through their involvement in transplant centers or treatment programs, and information is collected annually to assess outcomes like stem cell transplant recovery and marrow toxic injury status. The study monitors recipients, donors, and individuals with marrow toxic injuries over time, gathering detailed observational data to support future research. Participation duration varies as data are collected continuously from multiple sources.
CONDITIONS
CIBMTR Research Database
You may qualify if you...
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to several years
Participants who undergo routine care are observed with annual assessments to collect comprehensive data on hematopoietic stem cell transplantation and marrow toxic injuries.
Annual visits
Total: 2 locations
1
Center for International Blood and Marrow Transplant Research
Minneapolis, Minnesota, United States, 55413
Actively Recruiting
2
Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226
Actively Recruiting
L
Leigh Anne Blackmon
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ehab Atallah, Brent Logan, Min Chen...
https://pubmed.ncbi.nlm.nih.gov/31830234